The federal contract award is for the preparation and submission of genome data to GenBank, a genetic sequence database. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The prime contractor is IG Assets Inc., and the contract has a ceiling value of $6,000.00 with a firm fixed price. The contract does not have a set-aside designation. The award was made on June 7, 2011, with a completion date of July 25,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $59,850 firm fixed price purchase order to Broad Clinical Laboratories, LLC, a subsidiary of the Broad Institute. The contract is for the delivery of 150 clinical whole genome sequencing services, with a completion date of September 30, 2024. Broad Clinical Laboratories is a specialized healthcare services provider that offers genetic testing and clinical genome sequencing to federal agencies, particularly the Department...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
This is a definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $156,240,393.28, is for "Other Function - Microbial Genome Centers" and does not have a set-aside designation. The contract was awarded on September 15, 2003, with a completion date of December 31, 2009. The contract type is Cost No Fee, indicating the contractor is...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $145,590 purchase order to Clinical Research Sequencing Platform, LLC for clinical genome sequencing services. The prime contractor, Clinical Research Sequencing Platform, LLC, is a division of The Broad Institute, Inc. doing business as Broad Institute of MIT and Harvard. The firm fixed price contract runs from August 30, 2023 through December 31, 2023 to...
This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, is for $20,000.00 in custom gene synthesis and expression services provided by Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. While the original solicitation is not provided, the award likely...
This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $44,669.06, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 28, 2020. Illumina, Inc. is the prime...
This is a $10,594.44 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey, without a set-aside designation. The contract requires Genscript to provide a range of molecular biology products and services, including gene synthesis, gene...
This is a Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Godx Inc., a minority-owned small business. The $1,596,552.00 contract is for the development of a rapid, low-cost, point-of-care diagnostic test to detect enteric pathogens and antibiotic resistance. The goal is to create a diagnostic tool that can identify cholera, salmonella, shigella, and other...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $249,996 firm fixed price purchase order to Gene By Gene, LTD for clinical grade whole genome sequencing services. The contract calls for Gene By Gene to deliver these sequencing services from its Houston, Texas facility between September 1, 2023 and December 31, 2023 to support NIAID's research efforts in the areas of allergy and infectious disease. No...